Cologne, 4 September 2019 – Cannamedical® Pharma GmbH, one of the best-known medicinal cannabis companies in Germany and the European Union, is expanding its management team with experienced experts from the pharmaceutical industry. The independent importer and wholesaler has named Dr. med. Thomas Baur as Chief Commercial Officer (CCO). With immediate effect, the 41-year-old will be responsible for the areas of Medical Affairs, Marketing, Pharmacy and Field Sales, with a focus on providing professional advice and support to doctors, pharmacies and health insurers, as well as the expansion of the sales network.
“In Dr. Thomas Baur we have decided to employ one top expert. With his experience and industry knowledge we will strengthen our quality assurance and the expansion of the Cannamedical brand. Together we shall continue to extend our advantage as the largest and best-known independent importer of medicinal cannabis, and secure our success in Germany and the EU in the long term,” says David Henn, CEO and founder of Cannamedical.
For the last 15 years, Baur has held management positions in healthcare companies such as Fresenius, Medtronic and Grünenthal, specialising in pain therapy. Most recently, Baur’s responsibilities included commercial assessment and business development, and he was head of the business unit for the hospital business in the DACH region.
“I am delighted to be part of the Cannamedical team. Cannamedical already offers leading products and services to physicians and pharmacists, in order to enable patients to lead a life worth living. Our clear objective is to further extend our leading position in the market, and to redefine the quality of consultation provided to doctors, pharmacies and health insurers. Together we want to adapt new approaches to treatment and provide innovative therapy options in the form of medicinal cannabis to patients with various illnesses,” says Dr. Thomas Baur, CCO Cannamedical.
Founded in November 2016 by David Henn, Cannamedical is now the largest independent importer and wholesaler of medicinal cannabis in Germany. Based in Cologne, since commencing operations in 2017, Cannamedical now has more than 50 employees.
Phone: +49 221 999 852 51
About Cannamedical® Pharma GmbH
We at Cannamedical® Pharma GmbH are committed to helping doctors, medical specialists and pharmacists to improve their patients’ quality of life. The top-class products by Cannamedical concentrate on helping people with chronic illnesses to lead the best possible life with medicinal cannabis. To this end, we import and process only high-quality medicinal cannabis products and supply them to around 2,500 pharmacies and clinical facilities.
As well as the provision of top-class medicinal cannabis products, our focus is on training medical professionals, and providing sector-leading customer service. Our production partners worldwide must comply with the highest pharmaceutical quality standards – the so-called GMP guidelines (Good Manufacturing Practice). With its quality management, Cannamedical guarantees the highest product standards. We ourselves are GDP-certified (Good Distribution Practice), in other words, our entire supply chain is guaranteed, from the agricultural environment to the pharmacy. Cannamedical® Pharma GmbH was founded in Cologne in 2016 and employs more than 50 staff. In addition, Cannamedical operates subsidiaries in Canada and the UK.
For more information, visit www.cannamedical.com.
Photo of Dr. med. Thomas Baur at: https://cannamedical.de/foto-thomas-baur/
Photo of Dr. rer. nat. Ralf Bradenahl at: https://cannamedical.de/foto-ralf-bradenahl/
Photo of David Henn, CEO Cannamedical® Pharma GmbH at: https://cannamedical.de/foto-david-henn/